Cargando…
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark
SMDY3 is a histone-lysine N-methyltransferase involved in several oncogenic processes and is believed to play a major role in various cancer hallmarks. Recently, we identified ATM, BRCA2, CHK2, MTOR, BLM, MET, AMPK, and p130 as direct SMYD3 interactors by taking advantage of a library of rare tripep...
Autores principales: | Fasano, Candida, Lepore Signorile, Martina, Di Nicola, Elisabetta, Pantaleo, Antonino, Forte, Giovanna, De Marco, Katia, Sanese, Paola, Disciglio, Vittoria, Grossi, Valentina, Simone, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632561/ https://www.ncbi.nlm.nih.gov/pubmed/37954147 http://dx.doi.org/10.1016/j.csbj.2023.10.015 |
Ejemplares similares
-
Identifying novel SMYD3 interactors on the trail of cancer hallmarks
por: Fasano, Candida, et al.
Publicado: (2022) -
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
por: De Marco, Katia, et al.
Publicado: (2023) -
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
por: Lepore Signorile, Martina, et al.
Publicado: (2023) -
Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models
por: Lepore Signorile, Martina, et al.
Publicado: (2023) -
APC Splicing Mutations Leading to In-Frame Exon 12 or Exon 13 Skipping Are Rare Events in FAP Pathogenesis and Define the Clinical Outcome
por: Disciglio, Vittoria, et al.
Publicado: (2021)